Sotera Health Co
SHCNasdaq
$17.75
↓ -2.8%Jul 17 close · end-of-day
Price
1Y↑ +58.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$5.1B
Enterprise Value
$6.9B
P/E
43.3
P/S
4.3
P/B
8.2
EV/EBITDA
—
PEG
—
FCF Yield
1.9%
Dividend Yield
—
Revenue (TTM)
$1.2B
Net Income (TTM)
$117.8M
Free Cash Flow (TTM)
$96.8M
Gross Margin
55.3%
Operating Margin
—
Net Margin
9.9%
ROE
18.9%
ROIC
—
Debt / Equity
3.4
Net Cash
-$1.8B
Return 1Y
+58.1%
Company profile
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing. Nelson Labs comprise microbiological and analytical chemistry testing. It serves medical devices, pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries.
- CEO
- Michael B. Petras
- Sector
- Services
- Industry
- Healthcare
- Employees
- 3,000
- Headquarters
- Ohio
- Website
- soterahealth.com
Management & directors
- Shader AltonChief Executive Officer
- Dimitrief AlexanderFormer SVP, GC and Sec.
- Petras Michael B. Jr.Chairman & CEO
- Rutz Michael PPresident of Sterigenics
- Lyons Jonathan M.Sr. Vice President, CFO
Roles derived from SEC Form 4 filings.
Earnings
SHC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$280.0M↑ +10.0%
Diluted EPS$0.09↓ -280.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $818.2M | $931.5M | $1.0B | $1.0B | $1.1B | $1.2B |
| Gross profit | $443.6M | $518.7M | $557.0M | $577.2M | $602.3M | $645.5M |
| Operating income | $206.0M | $256.7M | $248.3M | $276.7M | $297.6M | — |
| Net income | -$38.6M | $116.2M | -$233.6M | $51.4M | $44.4M | $77.9M |
| Diluted EPS | -$0.16 | $0.41 | -$0.83 | $0.18 | $0.16 | $0.27 |
| Operating cash flow | $120.6M | $281.5M | $278.0M | -$147.7M | $224.2M | $287.2M |
| Free cash flow | $67.1M | $179.4M | $95.6M | -$362.7M | $45.1M | $149.2M |
| Gross margin | 54.2% | 55.7% | 55.5% | 55.0% | 54.7% | 55.5% |
| Operating margin | 25.2% | 27.6% | 24.7% | 26.4% | 27.0% | — |
| Net margin | -4.7% | 12.5% | -23.3% | 4.9% | 4.0% | 6.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $276.6M | $285.5M | $290.2M | $254.5M | $294.3M | $311.3M | $303.4M | $280.0M |
| Gross profit | $152.8M | $158.0M | $164.4M | $135.4M | $166.6M | $177.6M | $165.9M | $147.1M |
| Operating income | $76.8M | $80.5M | $87.1M | — | — | — | — | — |
| Net income | $8.8M | $17.0M | — | -$13.3M | $8.0M | $48.4M | $34.8M | $26.6M |
| Diluted EPS | $0.03 | $0.06 | $0.05 | -$0.05 | $0.03 | $0.17 | $0.12 | $0.09 |
| Operating cash flow | $61.3M | $97.5M | $55.7M | $55.5M | $57.4M | $71.2M | $103.1M | $29.4M |
| Free cash flow | $19.4M | $61.1M | -$10.2M | $35.6M | $26.2M | $35.0M | $52.4M | -$16.7M |
| Gross margin | 55.2% | 55.4% | 56.6% | 53.2% | 56.6% | 57.0% | 54.7% | 52.5% |
| Operating margin | 27.8% | 28.2% | 30.0% | — | — | — | — | — |
| Net margin | 3.2% | 6.0% | — | -5.2% | 2.7% | 15.5% | 11.5% | 9.5% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-26 | SHADER ALTON· Chief Executive Officer | Award | 375,939 | $0.00 | $0.00 | filing |
| 2026-05-26 | SHADER ALTON· Chief Executive Officer | Award | 203,634 | $0.00 | $0.00 | filing |
| 2026-05-22 | Klee Ann R. | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | Kyle Richard G | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | Krause Kenneth D. | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | CUNNINGHAM SEAN LAURENCE | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | Flynn Karen | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | Neary James | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | PETRELLA VINCENT K | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | Chen Ruoxi | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | Simon, Christopher | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-22 | Wheadon David E. | Award | 14,970 | $0.00 | $0.00 | filing |
| 2026-05-13 | WARBURG PINCUS & CO. | Sale | 19,102,952 | $15.17 | $289.8M | filing |
| 2026-05-13 | WARBURG PINCUS & CO. | Sale | 19,102,952 | $15.17 | $289.8M | filing |
| 2026-05-13 | GTCR INVESTMENT XI LLC | Sale | 12,735,301 | $15.17 | $193.2M | filing |
| 2026-03-31 | DIMITRIEF ALEXANDER· Former SVP, GC and Sec. | Tax withholding | 7,941 | $14.34 | $113,873.94 | filing |
| 2026-03-06 | WARBURG PINCUS & CO. | Sale | 15,000,000 | $15.27 | $229.1M | filing |
| 2026-03-06 | WARBURG PINCUS & CO. | Sale | 15,000,000 | $15.27 | $229.1M | filing |
| 2026-03-06 | GTCR INVESTMENT XI LLC | Sale | 10,000,000 | $15.27 | $152.7M | filing |
| 2026-03-02 | Petras Michael B. Jr.· Chairman & CEO | Tax withholding | 79,104 | $15.91 | $1.3M | filing |
| 2026-03-02 | Petras Michael B. Jr.· Chairman & CEO | Tax withholding | 40,302 | $15.91 | $641,204.82 | filing |
| 2026-03-02 | Petras Michael B. Jr.· Chairman & CEO | Tax withholding | 39,552 | $15.91 | $629,272.32 | filing |
| 2026-03-02 | Petras Michael B. Jr.· Chairman & CEO | Tax withholding | 31,339 | $15.91 | $498,603.49 | filing |
| 2026-03-02 | Petras Michael B. Jr.· Chairman & CEO | Award | 240,248 | $0.00 | $0.00 | filing |
| 2026-03-02 | Petras Michael B. Jr.· Chairman & CEO | Option exercise | 89,686 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.